subscribeSubscribe
Xiamen`s Generic Memantine, Donepezil Receives Approval in the U.S.

Xiamen`s Generic Memantine, Donepezil Receives Approval in the U.S.
FDA
07 Apr 2023
Share Share
AbbVie agrees to pay $54.4 mln in antitrust case over Alzheimer`s drug

AbbVie agrees to pay $54.4 mln in antitrust case over Alzheimer`s drug
REUTERS
15 Nov 2022
Share Share
Xiamen`s Generic Memantine Hydrochloride Receives Approval in the U.S.

Xiamen`s Generic Memantine Hydrochloride Receives Approval in the U.S.
FDA
11 Oct 2022
Share Share
Hetero`s Generic Memantine Hydrochloride Receives Approval in the U.S.

Hetero`s Generic Memantine Hydrochloride Receives Approval in the U.S.
FDA
26 Sep 2022
Share Share
Judge opts for jury trial in Alzheimer`s drug case

Judge opts for jury trial in Alzheimer`s drug case
Kevin Dunleavy FIERCE PHARMA
15 Jun 2021
Share Share
Polygen Pharms Generic Memantine Hydrochloride Receives Approval in US

Polygen Pharms Generic Memantine Hydrochloride Receives Approval in US
FDA
15 Dec 2020
Share Share
Neurotrope Announces 1st Patient Dosed in Long-Term Clinical Trial of Bryostatin

Neurotrope Announces 1st Patient Dosed in Long-Term Clinical Trial of Bryostatin
PRNEWSWIRE
06 Oct 2020
Share Share
Medley Pharmaceuticals`s Generic Daptomycin Receives Approval in US

Medley Pharmaceuticals`s Generic Daptomycin Receives Approval in US
FDA
02 Sep 2020
Share Share
Enforcement Report - Week of May 20, 2020

Enforcement Report - Week of May 20, 2020
FDA
21 May 2020
Share Share
Ningbo`s Generic Memantine Hydrochloride Receives Approval in US

Ningbo`s Generic Memantine Hydrochloride Receives Approval in US
FDA
04 Apr 2020
Share Share